Metrifonate or praziquantel treatment improves physical fitness and appetite of Kenyan schoolboys with Schistosoma haematobium and hookworm infections.
We studied physical fitness, as determined by the Harvard Step Test (HST), and appetite, as measured by the consumption of a morning snack (maize meal porridge), in primary school boys infected with Schistosoma haematobium (100% baseline prevalence) and hookworm (94-100% prevalence) who received a single dose of metrifonate (MT, 10 mg/kg body weight) or praziquantel (PR, 40 mg/kg body weight), or a placebo (PL). Five weeks after treatment, HST scores and porridge intake increased significantly in the MT and PR groups, but the PL group did not change. At the second examination, the MT group showed a significant decrease in S. haematobium egg counts (mean = 180 vs. 14 eggs/10 ml adj, P less than 0.0002, 82% egg reduction in arithmetic means) as did the PR group (mean = 198 vs. 0.1 eggs/10 ml adj, P less than 0.0002, 99.9% reduction); the egg counts in the PL group did not change. The MT group also exhibited a significant decrease in hookworm egg counts (mean = 1,550 vs. 75 eggs per gram feces [epg], P less than 0.0005, 80% reduction). Treatment with either drug may allow improved physical fitness and appetite in areas where S. haematobium and protein-energy malnutrition are highly prevalent.
Latham
M C
MC
Cornell University, Ithaca, New York.
Stephenson
L S
LS
Kurz
K M
KM
Kinoti
S N
SN
D000293:Adolescent; D000740:Anemia / Q000150:complications; D000886:Anthropometry; D001066:Appetite; D002648:Child; D005500:Follow-Up Studies; D006454:Hemoglobins / Q000032:analysis; D006725:Hookworm Infections / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D007630:Kenya; D008297:Male; D015999:Multivariate Analysis; D010270:Parasite Egg Count; D010809:Physical Fitness; D011223:Praziquantel / Q000627:therapeutic use*; D011502:Protein-Energy Malnutrition / Q000150:complications; D016032:Randomized Controlled Trials as Topic; D012044:Regression Analysis; D012553:Schistosomiasis haematobia / Q000150:complications / Q000188:drug therapy*; D014236:Trichlorfon / Q000627:therapeutic use*
D006454:Hemoglobins; D011223:Praziquantel; D014236:Trichlorfon